Viva Biotech Holdings
Company Profile
Business description
Viva Biotech Holdings is engaged in providing the structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development. The company operates in three reportable segments, Drug Discovery Services providing structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development; Contract Development Manufacture Organisation providing contract development and manufacturing services for small molecule APIs and intermediates and trading of APIs, intermediates and formulations; and commercialisation services; and Viva BioInnovator making strategic investments in biotechnology startup companies.
Contact
735 Ziping Road
Pudong New District
Zhoupu Town
Shanghai201318
CHNT: +86 2160893288
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
2,085
Stocks News & Analysis
stocks
A top global stock to buy after a big change in its forecast
stocks
Does the AI trade still have room to run?
stocks
More gas left in the tank for ASX highflyer
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,189.90 | 15.70 | 0.17% |
| CAC 40 | 8,131.15 | 11.90 | -0.15% |
| DAX 40 | 24,933.08 | 32.37 | 0.13% |
| Dow JONES (US) | 49,412.40 | 313.69 | 0.64% |
| FTSE 100 | 10,148.85 | 5.41 | 0.05% |
| HKSE | 26,765.52 | 135.56 | 0.51% |
| NASDAQ | 23,601.36 | 100.11 | 0.43% |
| Nikkei 225 | 52,885.25 | 803.64 | -1.50% |
| NZX 50 Index | 13,423.39 | 37.35 | -0.28% |
| S&P 500 | 6,950.23 | 34.62 | 0.50% |
| S&P/ASX 200 | 8,860.10 | 15.00 | 0.17% |
| SSE Composite Index | 4,132.60 | 3.56 | -0.09% |